DATATRAK International, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter Ended September 30, 2018
November 07, 2018 at 03:08 pm EST
Share
DATATRAK International, Inc. reported unaudited consolidated earnings results for the third quarter ended September 30, 2018. For the quarter, the company's revenue was $1,846,940 compared to $1,736,872 a year ago. Income from operations was $91,869 compared to loss of $4,873 a year ago. Net income before income taxes was $91,550 compared to loss of $42,058 a year ago. Net income was $91,550 compared to loss of $42,058 a year ago. Basic and diluted net income per share was $0.04 compared to $0.02 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
